β-内酰胺酶抑制剂CP-45,899与β-内酰胺类抗生素联合对多重耐药肠杆菌科细菌和假单胞菌属细菌的协同作用不一致。
Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species.
作者信息
Fass R J
出版信息
Antimicrob Agents Chemother. 1981 Feb;19(2):361-3. doi: 10.1128/AAC.19.2.361.
Abstract
Synergy between CP-45,899 and ampicillin or newer beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and Pseudomonas species was inconsistent. In contrast, synergy between CP-45,899 and ampicillin against beta-lactamase-producing strains of Haemophilus influenzae type b and Bacteroides fragilis was consistent and marked.
摘要
CP-45899与氨苄西林或新型β-内酰胺类抗生素联合使用对抗多重耐药肠杆菌科细菌和假单胞菌属细菌时，协同作用并不一致。相比之下，CP-45899与氨苄西林联合使用对产β-内酰胺酶的b型流感嗜血杆菌菌株和脆弱拟杆菌的协同作用则是持续且显著的。
相似文献
1
Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species.
Antimicrob Agents Chemother. 1981 Feb;19(2):361-3. doi: 10.1128/AAC.19.2.361.
2
Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
J Antimicrob Chemother. 1986 Apr;17(4):463-9. doi: 10.1093/jac/17.4.463.
3
Synergistic activity of piperacillin in combination with beta-lactamase inhibitors.
Antimicrob Agents Chemother. 1980 Oct;18(4):582-5. doi: 10.1128/AAC.18.4.582.
4
Effect of pO2 and pH on synergy of tazobactam and beta-lactam antibiotics against beta-lactamase producing Enterobacteriaceae.
J Antimicrob Chemother. 1995 Sep;36(3):513-9. doi: 10.1093/jac/36.3.513.
5
A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.
J Antibiot (Tokyo). 1978 Dec;31(12):1238-44. doi: 10.7164/antibiotics.31.1238.
6
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
J Antimicrob Chemother. 1986 Aug;18(2):177-84. doi: 10.1093/jac/18.2.177.
7
Activity of beta-lactamase inhibitors in combination with new beta-lactam antibiotics against resistant gram-negative organisms.
Diagn Microbiol Infect Dis. 1984 Jun;2(3):255-60. doi: 10.1016/0732-8893(84)90039-7.
8
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
Antimicrob Agents Chemother. 1986 Jun;29(6):980-5. doi: 10.1128/AAC.29.6.980.
9
Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.
Antimicrob Agents Chemother. 1986 Nov;30(5):789-91. doi: 10.1128/AAC.30.5.789.
10
6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization.
Antimicrob Agents Chemother. 1981 Sep;20(3):327-31. doi: 10.1128/AAC.20.3.327.
引用本文的文献
1
Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Drugs. 1987 Jun;33(6):577-609. doi: 10.2165/00003495-198733060-00003.
2
In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
Antimicrob Agents Chemother. 1985 May;27(5):876-8. doi: 10.1128/AAC.27.5.876.
3
In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.
Antimicrob Agents Chemother. 1989 Sep;33(9):1580-7. doi: 10.1128/AAC.33.9.1580.
4
In vitro activities of cefoperazone and sulbactam singly and in combination against cefoperazone-resistant members of the family Enterobacteriaceae and nonfermenters.
Antimicrob Agents Chemother. 1990 Nov;34(11):2256-9. doi: 10.1128/AAC.34.11.2256.
本文引用的文献
1
Interaction of clindamycin and gentamicin in vitro.
Antimicrob Agents Chemother. 1974 Nov;6(5):582-7. doi: 10.1128/AAC.6.5.582.
2
Activity of beta-lactamase produced by Bacteroides fragilis against newly introduced cephalosporins.
Antimicrob Agents Chemother. 1980 Apr;17(4):736-7. doi: 10.1128/AAC.17.4.736.
3
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Antimicrob Agents Chemother. 1980 Apr;17(4):757-61. doi: 10.1128/AAC.17.4.757.
4
CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.
Antimicrob Agents Chemother. 1980 Apr;17(4):615-22. doi: 10.1128/AAC.17.4.615.
5
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Antimicrob Agents Chemother. 1980 Feb;17(2):273-9. doi: 10.1128/AAC.17.2.273.
6
The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics.
J Antimicrob Chemother. 1976 Jun;2(2):115-57. doi: 10.1093/jac/2.2.115.
7
In vitro activity of LY127935.
Antimicrob Agents Chemother. 1979 Oct;16(4):503-9. doi: 10.1128/AAC.16.4.503.
8
Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis.
Antimicrob Agents Chemother. 1979 Feb;15(2):263-8. doi: 10.1128/AAC.15.2.263.
9
Comparative inhibition beta-lactamases by novel beta-lactam compounds.
Antimicrob Agents Chemother. 1979 Feb;15(2):171-6. doi: 10.1128/AAC.15.2.171.
10
A sulfone beta-lactam compound which acts as a beta-lactamase inhibitor.
J Antibiot (Tokyo). 1978 Dec;31(12):1238-44. doi: 10.7164/antibiotics.31.1238.
Zotero 插件